Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2016, Article ID 2652174, 23 pages
http://dx.doi.org/10.1155/2016/2652174
Research Article

Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases

Department of Dermatology, China National Nuclear Corporation (CNNC) 416 Hospital, No. 4 Er Huan Lu Bei Si Duan, Chengdu, Sichuan 610051, China

Received 31 March 2016; Revised 19 June 2016; Accepted 14 July 2016

Academic Editor: Christian Koch

Copyright © 2016 Changgui Lan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Humbert, J. L. Dupond, and J. P. Carbillet, “Pretibial myxedema: an overlapping clinical manifestation of autoimmune thyroid disease,” The American Journal of Medicine, vol. 83, no. 6, pp. 1170–1171, 1987. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Salvi, F. De Chiara, E. Gardini et al., “Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease,” European Journal of Endocrinology, vol. 131, no. 2, pp. 113–119, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. E. M. Watson, “Localized (pretibial) myxedema,” Canadian Medical Association Journal, vol. 54, no. 3, pp. 260–265, 1946. View at Google Scholar
  4. L. Bartalena and V. Fatourechi, “Extrathyroidal manifestations of Graves' disease: a 2014 update,” Journal of Endocrinological Investigation, vol. 37, no. 8, pp. 691–700, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Lan, W. Chen, J. Zhao, C. Li, X. Mei, and J. Hu, “Prevalence and clinical characteristics of pretibial myxedema in chinese outpatients with thyroid diseases,” Journal of Endocrinology and Metabolism, vol. 5, no. 4, pp. 250–255, 2015. View at Publisher · View at Google Scholar
  6. J. A. Couto, B. A. Schmidt, and A. K. Greene, “Nodular foot myxedema masquerading as lymphedema,” Plastic and Reconstructive Surgery Global Open, vol. 3, no. 7, e457, 2015. View at Publisher · View at Google Scholar
  7. L. O. Ramos, P. C. Mattos, G. L. P. de Figueredo, A. A. A. Maia, and S. A. R. Romero, “Pre-tibial myxedema: treatment with intralesional corticosteroid,” Anais Brasileiros de Dermatologia, vol. 90, supplement 1, no. 3, pp. S143–S146, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. P. A. Nair, A. Mishra, and A. Chaudhary, “Pretibial myxedema associated with euthyroid Hashimoto's thyroiditis: a case report,” Journal of Clinical and Diagnostic Research, vol. 8, no. 6, pp. YD01–YD02, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. W. B. Kim, N. Mistry, A. Alavi, C. Sibbald, and R. G. Sibbald, “Pretibial myxedema: case presentation and review of treatment options,” International Journal of Lower Extremity Wounds, vol. 13, no. 2, pp. 152–154, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Yu, X. Jiang, M. Pan, and R. Huang, “Elephantiasic pretibial myxedema in a patient with graves disease that resolved after 131I treatment,” Clinical nuclear medicine, vol. 39, no. 8, pp. 758–759, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Bartholomew, “LATS activity, hyperthyroidism, exophthalmos, pretibial myxoedema and acropachy,” British Journal of Clinical Practice, vol. 26, no. 9, pp. 431–433, 1972. View at Google Scholar · View at Scopus
  12. V. Fatourechi, “Pretibial myxedema: pathophysiology and treatment options,” American Journal of Clinical Dermatology, vol. 6, no. 5, pp. 295–309, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. B. Odom, W. D. James, and T. G. Berger, “Chapter 2: cutaneous symptoms, signs and diagnosis,” in Andrews' Disease of the Skin-Clinical Dermatology, pp. 13–20, Harcourt Publisher Limited, 9th edition, 2000. View at Google Scholar
  14. R. J. Cairns, “Pretibial myxoedema,” in Textbook of Dermatology, A. Rook, D. S. Wilkinson, and F. J. G. Ebling, Eds., pp. 2080–2081, Blackwell, Oxford, UK, 3rd edition, 1979. View at Google Scholar
  15. M. P. Mourits, M. F. Prummel, W. M. Wiersinga, and L. Koornneef, “Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy,” Clinical Endocrinology, vol. 47, no. 1, pp. 9–14, 1997. View at Publisher · View at Google Scholar
  16. E. Melcescu, W. B. Horton, D. Kim et al., “Graves orbitopathy: update on diagnosis and therapy,” Southern Medical Journal, vol. 107, no. 1, pp. 34–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Lan, C. Li, W. Chen, X. Mei, J. Zhao, and J. Hu, “A randomized controlled trial of intralesional glucocorticoid for treating pretibial myxedema,” Journal of Clinical Medicine Research, vol. 7, no. 11, pp. 862–872, 2015. View at Publisher · View at Google Scholar
  18. C. Lan, C. Li, M. Yang et al., “Pretibial myxoedema with autoimmunity and hyperplasia treated with glucocorticoids and surgery,” British Journal of Dermatology, vol. 166, no. 2, pp. 457–459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Lan, C. Li, M. Yang et al., “Surgical therapy for tumorous pretibial myxedema,” Journal of Clinical Dermatology, vol. 43, no. 11, pp. 688–690, 2014. View at Google Scholar
  20. D. Villalta, E. Orunesu, R. Tozzoli et al., “Analytical and diagnostic accuracy of ‘second generation’ assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers,” Journal of Clinical Pathology, vol. 57, no. 4, pp. 378–382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. K. M. Schwartz, V. Fatourechi, D. D. F. Ahmed, and G. R. Pond, “Extensive personal experience: dermopathy of graves' disease (pretibial myxedema): long-term outcome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 438–446, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. T. J. Smith, R. S. Bahn, and C. A. Gorman, “Connective tissue, glycosaminoglycans, and diseases of the thyroid,” Endocrine Reviews, vol. 10, no. 3, pp. 366–391, 1989. View at Publisher · View at Google Scholar
  23. M. K. Cowman, T. A. Schmidt, P. Raghavan, and A. Stecco, “Viscoelastic properties of hyaluronan in physiological conditions,” F1000Research, vol. 4, article 622, 2015. View at Publisher · View at Google Scholar
  24. D. Ponnusamy and R. P. A. R. Pai, “Nodular pretibial myxoedema after treatment of Graves disease with radioactive iodine ablation therapy,” BMJ Case Reports, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Dharmalingam, G. Seema, B. Khaitan, A. Karak, and A. C. Ammini, “Plaque form of pretibial myxedema in hypothyroidism,” Indian Journal of Dermatology, Venereology and Leprology, vol. 67, no. 6, pp. 330–331, 2001. View at Google Scholar
  26. Y.-Y. Lu and K.-C. Wei, “Elephantiasic pretibial myxedema,” Internal Medicine, vol. 51, no. 19, article 2837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Pingsmann, H. M. Ockenfels, and T. Patsalis, “Surgical excision of pseudotumorous pretibial myxedema,” Foot and Ankle International, vol. 17, no. 2, pp. 107–110, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Sendhil Kumaran, P. Dutta, U. Sakia, and S. Dogra, “Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India,” International Journal of Dermatology, vol. 54, no. 8, pp. e280–e286, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Fatourechi, M. Pajouhi, and A. F. Fransway, “Dermopathy of graves disease (pretibial myxedema): review of 150 cases,” Medicine, vol. 73, no. 1, pp. 1–7, 1994. View at Google Scholar · View at Scopus
  30. S. C. Missner, E. W. Ramsay, H. E. Houck, and C. L. Kauffman, “Grave's Disease presenting as localized myxedema in a thigh donor graft site,” Journal of the American Academy of Dermatology, vol. 39, no. 5, pp. 846–849, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. B. P. Luczak, J. Ha, and L. G. Teh, “Localized myxedema of the foot associated with trauma and surgery,” The Ochsner Journal, vol. 11, no. 2, pp. 132–138, 2011. View at Google Scholar
  32. Y. Shishiba, Y. Imai, R. Odajima, Y. Ozawa, and T. Shimizu, “Immunoglobulin G of patients with circumscribed pretibial myxedema of Graves' disease stimulates proteoglycan synthesis in human skin fibroblast in culture,” Acta Endocrinologica, vol. 127, no. 1, pp. 44–51, 1992. View at Google Scholar · View at Scopus
  33. C. Daumerie, M. Ludgate, S. Costagliola, and M. C. Many, “Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy,” European Journal of Endocrinology, vol. 146, no. 1, pp. 35–38, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. R. S. Douglas, N. F. Afifiyan, C. J. Hwang et al., “Increased generation of fibrocytes in thyroid-associated ophthalmopathy,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 1, pp. 430–438, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. P. Kriss, V. Pleshakov, and J. R. Chien, “Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema,” The Journal of Clinical Endocrinology and Metabolism, vol. 24, pp. 1005–1028, 1964. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Rapoport, R. Alsabeh, D. Aftergood, and S. M. McLachlan, “Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease,” Thyroid, vol. 10, no. 8, pp. 685–692, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Macchia, R. Concetti, F. Borgoni, F. Cetani, G. F. Fenzi, and A. Pinchera, “Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness,” Autoimmunity, vol. 3, no. 2, pp. 103–112, 1989. View at Publisher · View at Google Scholar · View at Scopus
  38. S.-R. Shih, M.-S. Lin, H.-Y. Li et al., “Observing pretibial myxedema in patients with Graves' disease using digital infrared thermal imaging and high-resolution ultrasonography: for better records, early detection, and further investigation,” European Journal of Endocrinology, vol. 164, no. 4, pp. 605–611, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. K. Eckstein, M. Plicht, H. Lax et al., “Thyrotropin receptor autoantibodies are independent risk factors for graves' ophthalmopathy and help to predict severity and outcome of the disease,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, pp. 3464–3470, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. J. Woo, S. Y. Jang, T. H. Lim, and J. S. Yoon, “Clinical association of thyroid stimulating hormone receptor antibody levels with disease severity in the chronic inactive stage of Graves' orbitopathy,” Korean Journal of Ophthalmology, vol. 29, no. 4, pp. 213–219, 2015. View at Publisher · View at Google Scholar
  41. A. E. Heufelder, R. S. Bahn, and P. C. Scriba, “Analysis of T-cell antigen receptor variable region gene usage in patients with thyroid-related pretibial dermopathy,” Journal of Investigative Dermatology, vol. 105, no. 3, pp. 372–378, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Lan and G. Zhou, “Advances in the mechanisms of initiation and progression of pretibial myxedema,” International Journal of Dermatology and Venereo, vol. 36, no. 3, pp. 155–158, 2010. View at Google Scholar
  43. N. Takasu, H. Higa, and Y. Kinjou, “Treatment of pretibial myxedema (PTM) with topical steroid ointment application with sealing cover (steroid occlusive dressing technique: steroid ODT) in Graves' patients,” Internal Medicine, vol. 49, no. 7, pp. 665–669, 2010. View at Publisher · View at Google Scholar · View at Scopus